Results 231 to 240 of about 269,422 (292)

Safety and Tolerability of Accelerated Venom Immunotherapy with Depot Extracts in Insect-Venom-Allergic Patients. [PDF]

Medicina (Kaunas)
Branicka O, Krupa-Lubas E, Bożek A, Balner T, Gawlik R.   +4 more
europepmc   +1 more source

Classification of Seasonal Allergic Rhinitis Patients by Prospective Patient‐Recorded Symptoms: The @IT.2020 Project

Allergy, EarlyView.
Daily prospective symptom reports from participants in this multicentre observational study were compared to retrospective (last 12 months) reports based on ARIA clinical questionnaire. Retrospective reports substantially underestimated, and to a lesser extent overestimated, symptom frequency compared to e‐Diary prospective reports. Since retrospective
Stephanie Dramburg, Camilo J. Hernandez Toro, Ulrike Grittner, Ekaterina Potapova, Alessandro Travaglini, Salvatore Tripodi, Stefania Arasi, Simone Pelosi, Francesco Monnati, Aydan Acar Şahin, Xenophon Aggelidis, Andrea Barbalace, Anne Bourgoin, Blerina Bregu, Maria Antonia Brighetti, Elsa Caeiro, Sule Caglayan Sozmen, Lucia Caminiti, Denis Charpin, Mariana Couto, Luís Delgado, Andrea Di Rienzo Businco, Claire Dimier, Maria V. Dimou, João A. Fonseca, Ozlem Goksel, Dolores Hernandez, Tara Maria Hoffmann, Dah Tay Jang, Fusun Kalpaklioglu, Blerta Lame, Ruth Llusar, Michael P. Makris, Angel Mazon, Eris Mesonjesi, Antonio Nieto, Ayse Bilge Öztürk, Laurie Pahus, Giovanni Battista Pajno, Ilenia Panasiti, Nikolaos G. Papadopoulos, Elisabetta Pellegrini, Ana Margarida Pereira, Mariana Pereira, Munevver Pinar, Alfred Priftanji, Fotis Psarros, Cansin Sackesen, Ifigenia Sfika, Javier Suarez, Michel Thibaudon, Ulas Uguz, Valentine Verdier, Valeria Villella, Paraskevi Xepapadaki, Duygu Yazici, Paolo M. Matricardi   +56 more
wiley   +1 more source

Criteria for Control and Remission of Respiratory Allergic Disease With Allergen Immunotherapy: A Delphi Consensus. [PDF]

Clin Transl Allergy
González-Mancebo E, Beitia Mazuecos JM, Tabar Purroy AI, Gandolfo-Cano M, Izquierdo-Domínguez A, Castillo Marchuet MJ, Bravo CC, Cereijo LD, Enríquez-Matas A, Gorgojo IE, Sánchez AG, Guerrero AJ.   +11 more
europepmc   +1 more source

Skin Abnormalities at Checkpoint Inhibitor Therapy Initiation Are Associated With Skin Rash Development in Oncology Patients

Allergy, EarlyView.
Skin tape strip lipidomic analysis revealed preexisting skin barrier lipid abnormalities at day 0 that were further exacerbated after 6 weeks of CPI treatment. Significant changes in skin (but not plasma) proinflammatory cytokines were identified in future ircAE patients after 6 weeks of CPI immunotherapy.
Taras Lyubchenko, Evgeny Berdyshev, Ryan M. Weight, Olivia Xiao, Neil J. Shah, Alina Markova, Mario E. Lacouture, Jeffrey A. Kern, Elena Goleva, Donald Y. M. Leung   +9 more
wiley   +1 more source

Safety and Effectiveness of Subcutaneous Immunotherapy with an Undiluted Glutaraldehyde-Polymerized Pollen Extract Mixture in Adults and Children with Allergic Rhinitis with or Without Asthma Due to Olive and Grass Pollen. [PDF]

Diseases
López-González P, Padial Vilchez MA, Palomeque Rodríguez MT, Dávila-Fernández MG, Bellido Linares V, Funes Vera E, Cordobés Durán C, Montoro Ferrer A, Moreno Mata E, Villalobos Violán V, Ortega-Martín L, Gómez-Cardenosa A.   +11 more
europepmc   +1 more source

Three‐Year Post‐Treatment Outcomes Following Cessation of Peanut Oral Immunotherapy: Comparisons by Clinical Allergy Status and Treatment Group

Allergy, EarlyView.
Paxton Loke, Xiaofang Wang, Sophie Rosser, Melanie Lloyd, Sarah E. Ashley, Adriana C. Lozinsky, Julie Burns, Patrick Quinn, Michael D. O'Sullivan, Michael Gold, Francesca Orsini, Mimi L. K. Tang   +11 more
wiley   +1 more source

Basophils in Immunity: Activation Pathways, Roles in Allergy and AllergoOncology and Application of the Basophil Activation Test

Allergy, EarlyView.
ABSTRACT Basophils, the least abundant leukocytes, are increasingly recognised as potent immunomodulators. Upon activation, they rapidly release preformed granule‐associated mediators including histamine and lipid mediators such as LTC4, while cytokine production occurs over a longer timescale, contributing to downstream immune responses.
Jitesh Chauhan, Sofia Vlasova, Alicia Chenoweth, Debra H. Josephs, Heather J. Bax, Sophia N. Karagiannis   +5 more
wiley   +1 more source

Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome reactivated by the initiation of oral immunotherapy (OIT). [PDF]

Pediatr Allergy Immunol
Pelletier A, Couture J, Marois L.
europepmc   +1 more source

Efficacy and Safety of Intralymphatic Immunotherapy With Grass Allergoid and Microcrystalline Tyrosine: A Double‐Blind Randomised Placebo‐Controlled Trial

Allergy, EarlyView.
This is the first randomised placebo‐controlled trial of intralymphatic immunotherapy using a microcrystalline tyrosine‐adjuvanted grass pollen allergoid. Three ultrasound‐guided ILIT injections were well tolerated and reduced combined symptom‐medication scores compared with placebo. The findings support further optimisation and clinical development of
Lara Šošić, Stephan C. Flory, Claudia C. V. Lang, Emma C. Widmer, Alexandra Chabot, Johannes M. Schmid, Tobias Andermatt, David Melillo, Bjarke Hviid‐Vyff, Maibritt Mardahl, Peter Schmid‐Grendelmeier, Thomas M. Kündig, Hans Jürgen Hoffmann, Pål Johansen   +13 more
wiley   +1 more source

Deep phenotyping of infants and toddlers undergoing food oral immunotherapy (DINOSAUR): design and baseline characteristics of a prospective multi-omics cohort. [PDF]

Front Allergy
Schoos AM, Skov FR, Borge SV, Mak R, Wong T, Erdle SC, Sham HP, Vallance BA, Soller L, Chan ES.   +9 more
europepmc   +1 more source